Healthcare

By

Bret Jensen

 | May 20, 2016 | 11:00 AM EDT

AbbVie and Gilead Sciences are worth accumulating in a long and deep bear market for biotech.

By

James Passeri

 | May 20, 2016 | 9:43 AM EDT

The Canadian drugmaker's standoff with creditors escalated Friday after it received a notice of default from bondholders.

By

James Passeri

 | May 19, 2016 | 5:56 PM EDT

Just as shares of the drugmaker were beginning to pick up steam, analysts with Wells Fargo Capital quickly put out the rally.

By

Jared Woodard

 | May 18, 2016 | 10:53 AM EDT

This is a trade expressing the view that flat-to-lower prices are ahead.

By

Robert Lang

 | May 18, 2016 | 9:00 AM EDT

A potentially bullish pattern is setting up. 

By

James Passeri

 | May 17, 2016 | 5:49 PM EDT

Shares of the struggling Canadian drugmaker continue a two-day rally  off news its most notorious short seller has changed his course.

By

Carleton English

 | May 17, 2016 | 5:42 PM EDT

One day after announcing a long position on Valeant, Andrew Left of Citron Research makes it clear he's still not a fan of Mallinckrodt.

By

Bret Jensen

 | May 17, 2016 | 10:00 AM EDT

It is hard to see much growth in the market overall, until earnings growth returns.

By

Paul Price

 | May 17, 2016 | 8:00 AM EDT

With ABC near a two-year low despite record profits, it no longer is overvalued like last year.

By

Bruce Kamich

 | May 16, 2016 | 4:23 PM EDT

Prices should 'catch their breath' and digest the sharp gains with some sideways movement.

Hewlett-Packard is ramping today following last night's earnings report. The stock ha...
As we did not fail at key resistance on the way up in the S&P and we also cleared the ...
Market slightly down as it digests two days of gains with less than three hours to go in t...
Market flat after two nice day of gains. Oil up above $50 a barrel, will be interesting t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.